NetraMark HoldingsAINMF -4.35%22 Market Cap is $41.11 Mil as of Jun. 27, 2026. GuruFocus rates AINMF with a GF Score™ of 22/100 and a GF Value™ of $0.21 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 697 Healthcare Providers & Services companies, NetraMark Holdings ranks worse than 63.41% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). NetraMark Holdings's share price for the quarter that ended in Mar. 2026 was $0.593. NetraMark Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 92.65 Mil. Therefore, NetraMark Holdings's market cap for the quarter that ended in Mar. 2026 was $54.94 Mil.
NetraMark Holdings's quarterly market cap
declined
from Sep. 2025 ($85.63 Mil) to Dec. 2025 ($70.51 Mil) and
declined
from Dec. 2025 ($70.51 Mil) to Mar. 2026 ($54.94 Mil).
NetraMark Holdings's annual market cap
declined
from Sep. 2023 ($16.28 Mil) to Sep. 2024 ($12.75 Mil) but then
increased
from Sep. 2024 ($12.75 Mil) to Sep. 2025 ($85.63 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. NetraMark Holdings's Enterprise Value for Today is $38.49 Mil.
NetraMark Holdings (OTCPK:AINMF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
NetraMark Holdings Market Cap Related Terms
NetraMark Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for NetraMark Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, NetraMark Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NetraMark Holdings Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where NetraMark Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
NetraMark Holdings's Market Cap for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NetraMark Holdings (AINMF) has a Market Cap of $41.11 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on NetraMark Holdings and its competitors. According to the industry distribution chart, NetraMark Holdings ranks #442 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 63.4%.
Is NetraMark Holdings' Market Cap too high?
NetraMark Holdings' current Market Cap is $41.11 Mil. The Healthcare Providers & Services industry median Market Cap is 93.63. NetraMark Holdings' value of $41.11 Mil is 56.1% below this industry median. Based on the distribution chart, NetraMark Holdings ranks #442 out of 697 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, NetraMark Holdings has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NetraMark Holdings' Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NetraMark Holdings ranks #442 out of 697 companies for Market Cap. This places NetraMark Holdings in the lower half of its industry. The industry median Market Cap is 93.63. NetraMark Holdings' value of $41.11 Mil is 56.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 93.63, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NetraMark Holdings's current Market Cap of $41.11 Mil is 56.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on NetraMark Holdings and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 93.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NetraMark Holdings's current Market Cap is $41.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NetraMark Holdings stock overvalued right now?
Based on GuruFocus' analysis, NetraMark Holdings (AINMF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.21, compared to a current price of $0.42 — trading 100.2% above its estimated fair value. The current Market Cap is $41.11 Mil and 56.1% below the Healthcare Providers & Services industry median of 93.63. NetraMark Holdings' overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For NetraMark Holdings (AINMF), the current Market Cap is $41.11 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NetraMark Holdings (AINMF) Overvalued in 2026?
Based on GuruFocus' analysis, NetraMark Holdings stock appears to be overvalued.
The current stock price of $0.42 is trading 100.2% above its estimated GF Value™ of $0.21.
GuruFocus considers NetraMark Holdings to be Significantly Overvalued.
Key valuation signals for AINMF:
Market Cap: $41.11 Mil
GF Value™: $0.21 vs. price of $0.42 (100.2% above fair value)
Industry Position: 56.1% below the Healthcare Providers & Services median (#442 of 697)
No single metric tells the full story. See the AINMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NetraMark Holdings Inc provides AI-powered insights and software solutions to optimize clinical trial design and outcomes for pharmaceutical sponsors. The company offers AI solutions to trial sponsors, CROs, and biotechnology companies across the globe. It earns revenue from its proprietary NetraAI platform, an advanced machine learning system purpose-built to analyze complex clinical trial data and identify meaningful patient subpopulations.
22GF Score
Get the complete analysis for AINMF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AINMF has been successfully added to your 
